Yangchun Zhou

631 total citations
11 papers, 516 citations indexed

About

Yangchun Zhou is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Biomaterials. According to data from OpenAlex, Yangchun Zhou has authored 11 papers receiving a total of 516 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Molecular Biology, 4 papers in Pulmonary and Respiratory Medicine and 4 papers in Biomaterials. Recurrent topics in Yangchun Zhou's work include Nanoparticle-Based Drug Delivery (4 papers), RNA Interference and Gene Delivery (2 papers) and Genetic factors in colorectal cancer (2 papers). Yangchun Zhou is often cited by papers focused on Nanoparticle-Based Drug Delivery (4 papers), RNA Interference and Gene Delivery (2 papers) and Genetic factors in colorectal cancer (2 papers). Yangchun Zhou collaborates with scholars based in China. Yangchun Zhou's co-authors include Lizong Shen, Hua Wei, Shoulin Wang, Cui‐Yun Yu, Dongxiu He, Cheng‐Hui Xu, Zhihong Zhang, Jianfei Wen, Tao Wang and Fei Gao and has published in prestigious journals such as Acta Biomaterialia, International Journal of Biological Macromolecules and Oncotarget.

In The Last Decade

Yangchun Zhou

10 papers receiving 511 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yangchun Zhou China 9 328 160 120 90 82 11 516
Jun Gu China 13 248 0.8× 88 0.6× 84 0.7× 60 0.7× 95 1.2× 39 520
Anna Brichkina Germany 10 243 0.7× 82 0.5× 94 0.8× 39 0.4× 63 0.8× 26 546
Suoyuan Li China 11 324 1.0× 87 0.5× 73 0.6× 86 1.0× 195 2.4× 22 556
Zhenwei Deng China 10 144 0.4× 94 0.6× 73 0.6× 70 0.8× 97 1.2× 20 378
Wen Song China 11 226 0.7× 108 0.7× 88 0.7× 96 1.1× 147 1.8× 34 500
Xiongjie Zhu China 13 321 1.0× 63 0.4× 67 0.6× 67 0.7× 180 2.2× 23 537
Yuejiao Zhong China 14 254 0.8× 130 0.8× 139 1.2× 94 1.0× 153 1.9× 32 576
Lingxiao Zhang China 8 359 1.1× 135 0.8× 53 0.4× 39 0.4× 70 0.9× 15 595

Countries citing papers authored by Yangchun Zhou

Since Specialization
Citations

This map shows the geographic impact of Yangchun Zhou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yangchun Zhou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yangchun Zhou more than expected).

Fields of papers citing papers by Yangchun Zhou

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yangchun Zhou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yangchun Zhou. The network helps show where Yangchun Zhou may publish in the future.

Co-authorship network of co-authors of Yangchun Zhou

This figure shows the co-authorship network connecting the top 25 collaborators of Yangchun Zhou. A scholar is included among the top collaborators of Yangchun Zhou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yangchun Zhou. Yangchun Zhou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Zhang, Chengfei, Yangchun Zhou, Minghua Hu, et al.. (2025). PLOD1 promotes the malignancy of hepatocellular carcinoma by facilitating the NF-κB/IL-6/STAT3-dependent TCA cycle. JHEP Reports. 7(5). 101329–101329.
2.
Zhang, Haitao, Yangchun Zhou, Cheng‐Hui Xu, et al.. (2022). Mediation of synergistic chemotherapy and gene therapy via nanoparticles based on chitosan and ionic polysaccharides. International Journal of Biological Macromolecules. 223(Pt A). 290–306. 12 indexed citations
3.
Huang, Wen, Cong Huang, Yangchun Zhou, et al.. (2020). Facile Fabrication of Nanoparticles with Dual-Targeting Ligands for Precise Hepatocellular Carcinoma Therapy In Vitro and In Vivo. Molecular Pharmaceutics. 17(9). 3223–3235. 34 indexed citations
4.
Xu, Cheng‐Hui, et al.. (2020). Cell membrane-camouflaged nanoparticles as drug carriers for cancer therapy. Acta Biomaterialia. 105. 1–14. 180 indexed citations
5.
Xu, Cheng‐Hui, et al.. (2019). Cell Membrane-Camouflaged Nanoparticles as Drug Carriers for Cancer Therapy. SSRN Electronic Journal. 1 indexed citations
6.
Wang, Yao, et al.. (2016). Aquaporin 3 facilitates chemoresistance in gastric cancer cells to cisplatin via autophagy. Cell Death Discovery. 2(1). 16087–16087. 65 indexed citations
7.
Zhou, Yangchun, Yao Wang, Jianfei Wen, et al.. (2016). Aquaporin 3 promotes the stem-like properties of gastric cancer cells via Wnt/GSK-3β/β-catenin pathway. Oncotarget. 7(13). 16529–16541. 41 indexed citations
8.
Zhou, Yangchun, Yao Wang, Shoulin Wang, & Lizong Shen. (2015). Hyperglycemia Promotes Human Gastric Carcinoma Progression via Aquaporin 3. Digestive Diseases and Sciences. 60(8). 2338–2345. 17 indexed citations
9.
Zhou, Yangchun, et al.. (2015). Preoperative Serum CEA and CA19-9 in Gastric Cancer - a Single Tertiary Hospital Study of 1,075 Cases. Asian Pacific Journal of Cancer Prevention. 16(7). 2685–2691. 43 indexed citations
10.
Yang, Xiaojun, Yangchun Zhou, Weiming Zhang, et al.. (2015). Potential role of aquaporin 3 in gastric intestinal metaplasia. Oncotarget. 6(36). 38926–38933. 12 indexed citations
11.
Chen, Jia, Tao Wang, Yangchun Zhou, et al.. (2014). Aquaporin 3 promotes epithelial-mesenchymal transition in gastric cancer. Journal of Experimental & Clinical Cancer Research. 33(1). 38–38. 111 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026